🇨🇦 Fluad_MF59-adjuvanted trivalent influenza subunit vaccine in Canada

Fluad_MF59-adjuvanted trivalent influenza subunit vaccine (Fluad_MF59-adjuvanted trivalent influenza subunit vaccine) regulatory status in Canada.

Marketing authorisation

Fluad_MF59-adjuvanted trivalent influenza subunit vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fluad_MF59-adjuvanted trivalent influenza subunit vaccine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Fluad_MF59-adjuvanted trivalent influenza subunit vaccine in Canada?

Novartis Vaccines is the originator. The local marketing authorisation holder may differ — check the official source linked above.